021-51111890
购物车（）
sales@molnova.cn
Coblopasvir
CAS No. 1312608-46-0
Coblopasvir ( KW136;KW-136 )
产品货号. M11255 CAS No. 1312608-46-0
Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥3807 | 有现货 |
|
| 10MG | ￥5581 | 有现货 |
|
| 25MG | ￥8748 | 有现货 |
|
| 50MG | ￥11826 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Coblopasvir
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection.
-
产品描述Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection.HCV Infection Phase 3 Clinical
-
同义词KW136;KW-136
-
通路Microbiology/Virology
-
靶点HCV
-
受体HCV
-
研究领域Infection
-
适应症HCV Infection
化学信息
-
CAS Number1312608-46-0
-
分子量782.90
-
分子式C41H50N8O8
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(OC)N[C@@H](C(C)C)C(N1[C@H](C2=NC(C3=CC=C(C4=C5OCOC5=C(C6=CNC([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC7)=N6)C=C4)C=C3)=CN2)CCC1)=O
-
化学全称methyl {(2S)-1-[(2S)-2-(4-{4-[7-(2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl)-2H-1,3-benzodioxol-4-yl]phenyl}-1Himidazol-2-yl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Balapiravir
The prodrug of R1479, a potent, specific and oral HCV NS5B polymerase inhibitor.
-
Chlorcyclizine
CHLORCYCLIZINE is a histamine H1 antagonist and a potent hepatitis C virus (HCV) entry inhibitor.
-
Sofosbuvir impurity ...
Sofosbuvir impurity F is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
